Annual report [Section 13 and 15(d), not S-K Item 405]

Note 13 - Stockholders' Equity (Tables)

v3.25.1
Note 13 - Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
               

Shares Subject to Purchase

 

Exercise Price per Share

   

Expiration Date

   

at December 31, 2024

 
$ 27.50       07/17/2028       18,193  
$ 25.00       08/04/2028       10,288  
$ 9.75       05/14/2029       39,125  
$ 7.80       05/14/2029       1,006,250  
$ 1.93       12/19/2029       425,000  
$ 1.92       12/19/2029       325,000  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Year ended December 31,

 
   

2024

   

2023

 

Cost of product sales

  $ 217     $ 130  

Research and development cost

    48       57  

General and administrative expense

    2,472       2,347  

Total

  $ 2,737     $ 2,534  
Share-based Payment Arrangement, Option and Restricted Stock Unit, Activity [Table Text Block]
           

Options Outstanding

   

PSUs Outstanding

   

RSUs Outstanding

 
                   

Weighted-

           

Weighted-

           

Weighted-

 
   

Number of

           

Average

           

Average

           

Average

 
   

Shares

           

Exercise

           

Grant Date

           

Grant Date

 
   

Available for

   

Number of

   

Price Per

   

Number of

   

Fair Value

   

Number of

   

Fair Value

 
   

Grant

   

Shares

   

Share

   

PSUs

   

Per Share

   

RSUs

   

Per Share

 

Balance at December 31, 2022

    263,113       49,713     $ 88.00           $       319,397     $ 18.20  

Granted

    (255,542 )                 23,764       11.25       231,778       17.00  

Released

                                  (133,846 )     19.80  

Forfeited

    16,081       (49,713 )     88.00                   (8,368 )     18.40  

Returned to Plan

    47,371                                      

Balance at December 31, 2023

    71,023                   23,764       11.25       408,961       17.20  

Granted

    (987,488 )                 158,817       2.15       828,671       1.48  

Released

                                  (177,641 )     16.54  

Forfeited

    188,294                   (2,400 )     11.25       (185,894 )     7.16  

Returned to Plan

    52,251                                      

Addition to 2019 Plan

    475,000                                      

Expiration of 2014 Plan

    (31,521 )                                    

Balance at December 31, 2024

    (232,441 )                 180,181     $ 3.23       874,097     $ 3.29  
           

Weighted-

 
           

Average

 
           

Grant Date

 
   

Number of

   

Fair Value Per

 
   

Shares

   

Share

 

Outstanding at January 1, 2024

    23,764     $ 11.25  

Granted

    79,408       1.36  

Forfeited

    (2,400 )     11.25  

Outstanding at December 31, 2024

    100,772     $ 3.64  
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
   

2024

   

2023

 

Volatility

    88.03 %     91.40 %

Risk-free interest rate

    4.26 %     4.30 %
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
           

Weighted-

 
           

Average

 
           

Grant Date

 
   

Number of

   

Fair Value Per

 
   

Shares

   

Share

 

Outstanding at January 1, 2024

        $  

Granted

    79,409       2.93  

Outstanding at December 31, 2024

    79,409     $ 2.93  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
   

Number of Shares

 

Equity Plan

       

Subject to outstanding options and restricted shares

    1,133,687  

Officer and Director Purchase Plan

    237,382  

Warrants

    1,823,856  

2022 Employee Stock Purchase Plan

    731,220  

Total reserved shares

    3,926,145